Table 4.
Multivariate analysis of OS in pancreatic cancer
| Hazard Ratio | 95% CI | P Value | |
|---|---|---|---|
| Treatment (A/B) | 0.193 | 0.105-0.354 | 0.000 |
| Age (< 65/≥ 65) | 0.929 | 0.468-1.843 | 0.833 |
| PS (0-1/2) | 0.686 | 0.400-1.179 | 0.172 |
| Previous Whipple procedure (yes/no) | 0.662 | 0.400-1.096 | 0.109 |
| Liver metastasis (yes/no) | 1.249 | 0.728-2.145 | 0.419 |
| Lung metastasis (yes/no) | 0.917 | 0.547-1.536 | 0.741 |
| Number of metastatic sites (1-3/> 3) | 0.642 | 0.342-1.206 | 0.168 |
| Differentiation (well+moderately/poorly) | 0.452 | 0.226-0.904 | 0.025 |
Abbreviations: A/B: HIFU+S-1/S-1; PS: performance status.